elizabeth loder, md, professor of neurology, harvard medical school; chief, division of headache, brigham & women's hospital..
stephen silberstein, md, director, jefferson university headache center.. september 2009 (17)....despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6..
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6..